Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.
about
Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLCSurvival data in elderly patients with locally advanced non-small cell lung cancer.Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary studyPhase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancerA phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with thoracic radiation for unresectable locally advanced non-small cell lung cancerComparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials.Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancerMUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patientsThe prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy.Evidence based radiation oncology with existing technologyRadiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer.Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapyBias and precision of measures of survival gain from right-censored data.Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer.Non-small cell lung cancer: the challenges of the next decadeLung cancer: Biology and treatment options.Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer PatientsSecond primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancerThe addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.Pros: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancer.Consolidation chwemotherapy after concurrent chemoradiotherapy vs. chemoradiotherapy alone for locally advanced unresectable stage III non-small-cell lung cancer: A meta-analysis.Sequencing postoperative radiotherapy and adjuvant chemotherapy in non-small cell lung cancer: unanswered questions on the not evidence-based approach.PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial.Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India.An alternative parameter for early forecasting clinical response in NSCLC patients during radiotherapy: proof of concept study.Combination of radiotherapy and chemotherapy in locally advanced NSCLC.Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer.A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancerWeekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patients.Guidelines for preclinical and early phase clinical assessment of novel radiosensitisersHistology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence.Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions.Inoperable stage III non-small cell lung cancer: Current treatment and role of vinorelbine.Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond.State of the art of radiotherapy.Treatment: Radiation Therapy.From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients.Dose-mass inverse optimization for minimally moving thoracic lesions.
P2860
Q26852202-05CB17B7-08E2-46B5-A9D1-F07888B5D73EQ30585615-CE4705B8-FF0E-4095-9285-8FDA1D3F6AA6Q30791401-B20E091F-3EA1-45DC-8DAA-38E6DEAC8C87Q33301768-77105902-2189-47EB-B94F-7C1649DF5364Q33401530-ADE2D171-150B-4ED0-ADF1-E150B3776F81Q33407408-865FAAB6-CE5D-4615-93D7-ECC251CDCE5AQ33414080-69C85EB6-DC9E-4E5E-8B02-A6AC9866E4F9Q33414911-A3D1A7E6-0AD2-4250-9697-1F9BC5F1E880Q33574955-BEC7C605-98E4-475D-A968-9E5E38B43767Q33829279-C5B343E0-EF12-410D-8E6C-74BE93B88527Q33922185-3DB01E8E-FDC7-4737-AC0F-49CFED364AF9Q34558856-98310B5A-6EE9-45B8-A747-A3180363EFF1Q35397008-286A254D-50E4-4C0A-B52D-3737545B8A4BQ35720400-B590BC35-6062-4128-8844-146B18B12E1EQ35939945-1E68ED07-019E-4068-BFEC-3AD0AC924E33Q35971331-D9618047-4245-4B9A-B8B1-D7581E0BA059Q36328370-F7EDA60D-335E-4680-8CB2-59B3C16FE1ECQ36536988-BFBA361F-515D-469F-B388-DBFF9AB8F223Q36611922-E5ABB37E-6950-4B09-A0C1-D3D69E134C59Q36823982-8E1D3566-2E33-4CC1-8178-1F5DF475D784Q36874790-8DB92496-D97E-4224-A495-FC02B1B3FF4BQ37108127-746DF0F7-50A5-44DC-90D8-0D81244A917FQ37121332-D642A97B-0299-46F6-B971-C6A8AD8507BEQ37417131-6B592F48-2AD0-4B10-921F-1BD743A1631BQ37467273-B85DF874-46B0-4303-AB5D-D4410432EA84Q37601150-48ECFA6C-3EF9-4460-B5BA-843E09391ECCQ37614572-E434F980-31FE-4585-B5C6-8F4132F3335FQ37670429-889A2492-7E52-407D-955F-B54F3FF481EDQ37716645-F082249D-2521-4F8D-932C-F49775F5B717Q37722169-312DEC70-4565-41EC-AAB2-8C3DFC1310B2Q37902873-7801EF91-565D-4B9F-AAE9-39C5C0E7E6B9Q37908174-3C569FBB-5416-4B5C-A82C-F07964230E0EQ37921958-733BD39B-1B24-4217-A634-05E56D196CB2Q37977438-BEC7BE6C-82EA-4FB6-9146-DCE9C4EBDACFQ38226816-3FB81C2E-2347-4DA3-BB06-3CD5660EDBE0Q38390036-4F73B1E1-FBA9-4647-9874-E3C464CFB8CBQ38930349-BD329C06-FF50-4869-B6AE-E4C3EC9D2F13Q39041541-465E2AF2-7265-4F4D-8B22-DB7038665AE5Q39737188-5910B045-9875-4CAE-80C1-30B7ADEF0C73Q40491681-1ABD3E62-8974-43F0-A04F-20E4309E98DE
P2860
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Concomitant radio-chemotherapy ...... idual data from 1764 patients.
@ast
Concomitant radio-chemotherapy ...... idual data from 1764 patients.
@en
type
label
Concomitant radio-chemotherapy ...... idual data from 1764 patients.
@ast
Concomitant radio-chemotherapy ...... idual data from 1764 patients.
@en
prefLabel
Concomitant radio-chemotherapy ...... idual data from 1764 patients.
@ast
Concomitant radio-chemotherapy ...... idual data from 1764 patients.
@en
P2093
P921
P356
P1433
P1476
Concomitant radio-chemotherapy ...... vidual data from 1764 patients
@en
P2093
C Le Péchoux
H J M Groen
J A Bonner
P304
P356
10.1093/ANNONC/MDJ117
P577
2006-03-01T00:00:00Z